Glaucoma Medications and Risk of Uveitis

Glaucoma Medications and Risk of Uveitis

Up next

Digital Mindfulness Intervention in Non-infectious Uveitis

Mental health of patients is often overlooked by physicians when treating them for physical diseases. Dr. Tsui interviews Dr. Jessica G. Shantha and Dr. Nisha R. Acharya on their study using the Calm Health app to improve the mental health outcomes in adults with noninfectious uv ...  Show more

Risks of Retinal Vascular Occlusions with Tyrosine Kinase Inhibitors

Dr. Rajesh Rao interviews Dr. Katherine E. Talcott on her Ophthalmology Retina article "Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors." They discuss the study which aimed to characterize the associations between systemic TKIs and the ris ...  Show more

Recommended Episodes

Rates of Visual Field Change in Individuals With and Without Glaucoma
JAMA Ophthalmology Author Interviews

Interview with Balwantray C. Chauhan, PhD, author of Rates of Visual Field Change in Patients With Glaucoma and Healthy Individuals: Findings From a Median 25-Year Follow-up 

Eye to Eye Ophthalmology: How to reduce the risk of endophthalmitis in patients attending for intravitreal injections
Eye to Eye: An Ophthalmology Podcast from the Royal College of Ophthalmologists

In this episode we speak with Quresh Mohamed, a Consultant Ophthalmologist from Cheltenham. We discuss his paper entitled, 'Post-injection endophthalmitis rates with reduced povidone-iodine prophylaxis in patients with self-reported iodine sensitivity'.


 

Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)
JAMA Ophthalmology Author Interviews

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howa ...  Show more